Avanir Pharmaceuticals to Participate in Two Conferences in August
ALISO VIEJO, Calif., Aug. 5, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the following conferences in August.
- Wedbush 2013 Life Sciences Management Access Conference
- Location: Le Parker Meridien, New York, NY
- Presentation date: Tuesday, August 13, 2013
- Presentation time: 12:45 p.m. E.T.
- Canaccord Genuity 33rd Annual Growth Conference
- Location: Intercontinental Boston Hotel, Boston, MA
- Presentation date: Wednesday, August 14, 2013
- Presentation time: 3:30 p.m. E.T.
A live webcast and 30-day archive of these presentations will be available at http://ir.avanir.com.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.
AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.
©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.
Avanir Investor & Media Contact
Ian Clements, PhD
+1 (949) 389-6700
SOURCE Avanir Pharmaceuticals, Inc.
More by this Source
Avanir Pharmaceuticals to Participate in Two Conferences in December
Nov 26, 2013, 08:30 ET
Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Nov 08, 2013, 16:00 ET
Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2013 Year End Financial Information
Oct 29, 2013, 08:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.